NCT00787761
- Conditions
- Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
- Locations
-
- Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT00110045
- Conditions
- Adnexal Diseases, Amyloidosis, Ataxia, +137 more
- Locations
-
- CHU Liege - Domaine Universitaire du Sart Tilman Liège, Belgium
- Centre Hospitalier Universitaire Henri Mondor Créteil, France
- Hopital Edouard Herriot - Lyon Lyon, France
- Hopital Saint-Louis Paris, France
NCT00003938
- Conditions
- Adnexal Diseases, Agranulocytosis, Amyloidosis, +147 more
- Locations
-
- A.Z. St. Jan Bruges, Belgium
- Institut Jules Bordet Brussels, Belgium
- Hopital Universitaire Erasme Brussels, Belgium
- U.Z. Gasthuisberg Leuven, Belgium
NCT00003805
- Conditions
- Blast Crisis, Blood Protein Disorders, Body Temperature Changes, +69 more
- Locations
-
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
- Boston Medical Center Boston, Massachusetts, United States
- Algemeen Ziekenhuis Middelheim Antwerp, Belgium
- Hopital Universitaire Erasme Brussels, Belgium
NCT00666211
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +108 more
- Locations
-
- Jennie Stuart Medical Center Hopkinsville, Kentucky, United States
- Mitchell Memorial Cancer Center at Owensboro Medical Health System Owensboro, Kentucky, United States
- Erlanger Health System Chattanooga, Tennessee, United States
- Tennessee Plateau Oncology Crossville, Tennessee, United States
Completed
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
NCT00710528
- Conditions
- Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
- Locations
-
- Stanford Cancer Center Palo Alto, California, United States
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT01108341
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Hematology Oncology, P.C. Stamford, Connecticut, United States
Completed
Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma
NCT00240565
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- GSK Investigational Site Calgary, Alberta, Canada
- GSK Investigational Site Edmonton, Alberta, Canada
- GSK Investigational Site Halifax, Nova Scotia, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
NCT00038857
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +20 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT00476229
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
- Locations
-
- U.T.M.D. Anderson Cancer Center Houston, Texas, United States